Xeris Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance

Xeris Biopharma Holdings, Inc. today announced financial results for the fourth quarter and full-year 2022 and provided 2023 financial guidance.